# The Vienna Prograf and Endothelial Progenitor Cell Study

> **NCT00182559** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 148 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Ciclosporin
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00182559
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2014-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182559, "The Vienna Prograf and Endothelial Progenitor Cell Study". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00182559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*